Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance

BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurogastroenterol Motil
Autors principals: Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Neurogastroenterology and Motility 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://ncbi.nlm.nih.gov/pubmed/29605979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars